Delivery Order SPE2DB24D3013-SPE2DB25FFQPC
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) valued at $3,391.20 with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract issued by the Medical Supply Chain, a division of the Defense Logistics Agency supporting the Department of Defense. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency awarded a $2,615.88 delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) with a ceiling value of $1,667.87. This firm fixed price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- The Defense Logistics Agency awarded a $1,240.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (two-unit package) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to deliver this emergency...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,447.92 firm fixed price delivery order contract for NARCAN 4 MG NASAL SPRAY 2S. This order was placed under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NARCAN 4 MG NASAL SPRAY 2S. This $1,619.64 award has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and performs the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under an indefinite delivery contract (IDC) with a...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,761.76 firm fixed price delivery order contract to supply NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQPCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,355.00 firm fixed-price delivery order for Narcan 4 mg nasal spray (2-pack units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical procurement contracts with the Defense Logistics Agency and serves critical healthcare needs across military and veteran systems. The company's competitive award history demonstrates its capability to fulfill diverse pharmaceutical supply requirements ranging from small-value transactions to substantial orders, with all reviewed contracts awarded through open competition on a firm fixed-price basis. This particular delivery order for Narcan—an opioid overdose reversal medication—aligns with the Department of Defense's broader medical supply chain operations and the company's established role as a comprehensive global pharmaceutical support vendor for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/15/25 |